Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
1 November 2021
The first CSC-CAMS/PUMC Oxford High Level Innovative Talent Scholarships DPhil Symposium was held on 30th Oct 2021 at the Peking University HSBC Business School.
30 June 2021
On the morning of 29th June 2021, the symposium “CAMS Oxford Joint Symposium- Clinical Medicine Research Without Borders” was held online, jointly organized by the Chinese Academy of Medical Sciences (CAMS) and CAMS-Oxford Institute (COI), and was attended by 1300 participants including Principal Investigators, researchers and students from Oxford and CAMS.
COVID Without Borders- A collaboration to Investigate A New Disease III – Vaccine Research and Development
18 December 2020
The webinar entitled “COVID Without Borders-A collaboration to Investigate A New Disease III – Diagnostic and Treatment for COVID-19” was held online on the morning of November 17th 2020, jointly organized by Chinese Academy of Medical Sciences (CAMS) and CAMS-Oxford Institute (COI).
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
COVID Without Borders - A collaboration to Investigate a New Disease II – Vaccine Research and Development
15 October 2020
The webinar entitled “COVID Without Borders - A collaboration to Investigate a New Disease II - Vaccine Research and Development” was held online on 22nd September 2020.
21 July 2020
On the morning of 1st July 2020, the webinar “COVID Without Borders – A collaboration to Investigate A New Disease” was held online. It was jointly organised by the Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College and CAMS-Oxford Institute (COI).
6 February 2020
The CAMS Oxford Institute has prioritised funding support in response to the current crisis caused by nCoV 2019, supporting positive actions taken by the Medical Sciences Divisions and University of Oxford.
23 December 2019
Delegates from the Ministry of Science and Technology and Chinese Embassy visited the CAMS Oxford Institute in December 2019.
2 December 2019
The CSC-CAMS/PUMC Oxford High-level Innovative Talent Scholarships and CSC-NDM Scholarships Interviews were held in Beijing in November 2019, representatives from the University of Oxford, the Chinese Academy of Medical Sciences (CAMS) and the Chinese Scholarship Council (CSC) were present.
28 November 2019
A new research discovered circulating antigen-specific CD103+CD8+ T cells can self-regulate their CD103 expression via production of active TGFβ1 and have better TCR signalling and effector function compared to CD103- populations.
COI Investigators Reported a Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
18 November 2019
COI Investigators (Xi Li, Ruozheng Wang are the joint first authors) reported a comprehensive analysis of key immune checkpoint receptors on T cells in 172 treatment-naïve, primary cancer patients from the eight most prevalent types of cancer.
CAMS Oxford Institute (COI) - Institute of Medicinal Plant Development (IMPLAD) Joint Symposium in Hainan
21 September 2019
The Chinese Academy of Medical Sciences Oxford Institute (COI) - Institute of Medicinal Plant Development (IMPLAD) Joint Symposium was held from September 21st to 22nd in Haikou, Hainan.
8 August 2019
Minister Counsellor Yongli Wang and First Secretary Haiyinh Yuan visited the COI on 9th August 2019.
4 July 2019
The Deputy Minister of Science and Technology Nanping Xu visited the CAMS Oxford Institute on 19th June 2019 accompanied by Minister Counsellor SuNan Jiang, Deputy Director of International Office Fengyun Lei, and attaché Ke Zhao to discuss its development and progress.
COI investigators led by Professor Tao Dong published data supporting cancer immunotherapy by targeting CD94/NKG2A
30 June 2019
COI investigators led by Professor Tao Dong published data (Abd Hamid M et al) supporting cancer immunotherapy by targeting CD94/NKG2A, to improve the long-term survivability of effector cells such as CD8+ T cells with better cytotoxic functions following combinatory anti-PD-1 treatment, especially in early stage cancer patients.
22 April 2019
President Chen Wang was accompanied by members of CAMS on a visit to Oxford in April 2019 to attend CAMS Oxford Institute update meetings and for the signing of the contract with Gavin Screaton.
COI investigators led by Professor Alain Townsend publish paper in Natural Microbiology about H7N9 Virus Infection
25 February 2019
COI investigators led by Professor Alain Townsend reported neutralization breadth of the H7-reactive antibody repertoire induced by natural H7N9 infection in humans and changes overtime, highlighted the need for updated H7N9 vaccines.
18 February 2019
On 14th February Minister Counsellor SuNan Jiang, First Secretary Ge Tan and First Secretary Jin Wang from the Chinese Embassy Science and Technology section met with Tao Dong, Darren Nash, Richard Liwicki, Chris Conlon, Andrew McMichael and Alain Townsend of the CAMS Oxford Institute to discuss its development and progress.